Dexcom stock closed at USD 84.53 on the Nasdaq on September 8, 2026, down 3.8 percent. The move left the shares 17.3 percent ...

As of August 27, 2026, Dexcom stock on Nasdaq is trading in the high-$80s region, with recent quotes clustering around $88.96 per share and situating the stock close to the prevailing $88.71 average ...

ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation, adoption and strong liquidity.

Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsJereme Sylvain - Executive VP, CFO ...

Abbott's Libre Duo 10 Day wins FDA authorization as the first CGM to monitor both glucose and ketones, helping prevent diabetic ketoacidosis.

Adults with type 1 diabetes who continued or transitioned to the Omnipod 5 Automated Insulin Delivery (AID) System maintained ...

Garmin patents reveal how the company is exploring wrist-based HbA1c tracking as Apple pursues its own non-invasive glucose monitoring technology.

Circular Ring 3 Slim and Pro add non-invasive glucose insights, contactless payments, haptic alerts, and up to 12 days of ...

The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a ...

The smart ring maker filed its S-1 with the SEC and plans to trade under the ticker "OURA" as it continues to expand into ...

According to MarketsandMarkets™, the mHealth Solutions Market is projected to reach USD 275.44 billion by 2031 from USD ...